GMALF yields 3.61% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, GMALF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GMALF + PFE for your $10,000?
Genting Malaysia Berhad, together with its subsidiaries, engages in the leisure and hospitality business in Malaysia, the United Kingdom, Egypt, the United States, and the Bahamas. It operates through Leisure & Hospitality, and Properties segments. The Leisure & Hospitality segment comprises integrated resort activities, which include gaming, hotels, food and beverage, theme parks, and retail and entertainment attractions, as well as tours and travel related, and other supporting services. The Properties segment is involved in the development and sale of land and properties, as well as letting of apartment units; and property investment and management activities. It also engages in the operation of casinos; and provision of information technology and consultancy services. In addition, the company provides investment, marketing, private debt securities issuance, training, administrative, show agency, condotel, golf resort, cable car and related support, creative and art, project and construction management, offshore financing, karaoke, payment and collection agency, loyalty programme, garbage collection and disposal, sewerage, investment trading, reinsurance, and resort management services. Further, it offers electricity supply, water, liquefied petroleum gas, and other services at Genting Highlands; operates sportsbooks; owns and operates aircraft; owns sea vessels; researches and develops software; and operates a video lottery facility. The company was formerly known as Resorts World Bhd. Genting Malaysia Berhad was incorporated in 1980 and is headquartered in Kuala Lumpur, Malaysia
Full GMALF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.